Finance

Lists
Why is 31R up 31,25%?
Dive Deeper
31R:FRA
Revive Therapeutics Ltd
0,010 €
+31,25%
(+0,0025) 1D
13 հոկ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
10,49 մլն
Avg. vol.
2,94 հզր
Volume
0,00
52-wk high
0,06 €
52-wk low
0,00 €
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
10,49 մլն
Avg. vol.
2,94 հզր
Volume
0,00
52-wk high
0,06 €
52-wk low
0,00 €
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersՏորոնտո, Օնտարիո, Կանադա
Sector-
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,32 հզր
200,14 հզր
283,25 հզր
242,05 հզր
Operating expense
336,39 հզր
220,13 հզր
283,30 հզր
463,87 հզր
Total operating expenses
336,39 հզր
220,13 հզր
283,30 հզր
463,87 հզր
Operating income
-336,39 հզր
-220,13 հզր
-283,30 հզր
-463,87 հզր
Other non operating income
73,85 հզր
-
-
-
EBT including unusual items
-9,60 մլն
-281,75 հզր
-238,72 հզր
-506,50 հզր
EBT excluding unusual items
-143,94 հզր
-281,75 հզր
-234,70 հզր
-506,50 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,60 մլն
-281,75 հզր
-238,72 հզր
-506,50 հզր
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277,00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277,00
-
-
Depreciation and amortization charges
62,00
46,00
48,00
47,00
EBITDA
-336,32 հզր
-220,08 հզր
-283,25 հզր
-463,82 հզր
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps